Quick Answer
NIKA PHARMACEUTICALS, INC reported Stockholders Equity of -$297.6 thousand for the year ending 2025.
- NIKA PHARMACEUTICALS, INC showed a decrease of -34.5% in Stockholders Equity from 2024 to 2025.
- This data is from NIKA PHARMACEUTICALS, INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: -$160.00 | Q1 2021: -$14.7 thousand | Q2 2021: -$17.6 thousand | Q3 2021: -$20.3 thousand | Q1 2022: $83.00 | Q2 2022: $4.1 thousand | Q3 2022: -$2.3 thousand | Q1 2023: -$36.9 thousand | Q2 2023: -$64.7 thousand | Q3 2023: -$74.8 thousand | Q1 2024: -$224.5 thousand | Q2 2024: -$208.8 thousand | Q3 2024: -$200.4 thousand | Q1 2025: -$234.2 thousand | Q2 2025: -$252.6 thousand | Q3 2025: -$260.5 thousand.
- Over the full 6 years of available data (2020 to 2025), NIKA PHARMACEUTICALS, INC's Stockholders Equity has declined by 3,241.5%.
- Historical annual values: Fiscal year 2025: -$297.6 thousand | Fiscal year 2024: -$221.2 thousand | Fiscal year 2023: -$82.1 thousand | Fiscal year 2022: -$17.3 thousand | Fiscal year 2021: -$23.6 thousand | Fiscal year 2020: -$8.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: